查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363304

術中神經監測市場規模、佔有率和趨勢分析報告：按類型、地區和細分市場分類的趨勢，2023-2030年

Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Type (Insourced, Outsourced), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

術中神經監測市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球術中神經監測市場規模將達46.5億美元，2023年至2030年年複合成長率為4.9%。

該成長歸因於技術進步、設備安全意識增強以及老年人口不斷成長。 COVID-19 的爆發預計將對市場產生雙重影響。2020年 3月，美國外科醫生學會 (ACS) 發表聲明，提案減少、推遲或取消擇期手術，因為美國的COVID-19 病例迅速增加，並稱這將阻礙成長。

此外，Elsevier雜誌（國際出血性中風協會；2021年1月）發表的一項研究發現，高達36%的住院COVID-19患者可能出現神經系統症狀，導致缺血性和出血性梗塞。與此相關的病例有多個。此外，2021年 6月發表在 Neurology Online Journal 上的另一項最新研究表明，COVID-19 病毒可能與新的神經系統疾病的發展有關。新疾病的增加增加了院內死亡風險並降低了出院率。這些特徵預計將在預測期內帶來良好的成長。

此外，由於神經外科手術的數量和負擔能力不斷增加，以及對手術期間病人安全的日益關注，預計該市場將會成長。術中神經監測（IONM）已被醫院廣泛應用於手術中，因為它可以減少再次手術的次數以及術後併發症和後遺症的發生。

術中神經監測市場報告亮點

  • 依類型分類，內包細分市場所佔佔有率最大，到2022年將達到 54.4%。這可能是由於患者和醫生對 IONM 益處的認知不斷提高，這導致醫院在複雜的手術中使用 IONM。這是IONM在該市場佔據主導地位的主要原因。
  • 依地區分類，北美地區佔比最大，2022年為49.3%。有利的償付方案和技術進步是這一優勢的原因。
  • 亞太地區預計在預測期內年複合成長率最快，達到 5.46%。這種成長可能是要素老年人口的增加、手術數量的增加以及醫療保健支出的增加。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 中神經監測市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 術中神經監測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 術中神經監測市場：依類型估計和趨勢分析

  • 術中神經監測市場：重點
  • 術中神經監測市場：2022年和2030年類型變動與市場佔有率分析
  • 內源
  • 外包

第5章 中神經監測市場：區域估計與趨勢分析

  • 區域預測
  • 依地區分類的術中神經監測市場：重點
  • 北美洲
    • 2018-2030年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Natus Medical Incorporated
    • Accurate Monitoring
    • Neuromonitoring Technologies
    • Medtronic
    • NuVasive, Inc.
    • SpecialtyCare
Product Code: GVR-1-68038-767-4

Intraoperative Neuromonitoring Market Growth & Trends:

The global intraoperative neuromonitoring market size is expected to reach USD 4.65 billion by 2030, registering a CAGR of 4.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.

Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.

Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.

Intraoperative Neuromonitoring Market Report Highlights:

  • By type, the insourced segment accounted for the largest share of 54.4% in 2022. This can be attributed to growing awareness among physicians as well as patients about the benefits of IONM, which results in the hospitals utilizing IONM during complex procedures. This is a key reason for the dominance of insourced IONM in the market
  • By region, North America accounted for the largest share of 49.3% in 2022. Favorable reimbursement scenarios along with technological advancements can be attributed to this dominance
  • Asia Pacific is expected to witness the fastest CAGR of 5.46% over the forecast period. The growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare can be attributed to this growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Intraoperative Neuromonitoring Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Intraoperative Neuromonitoring Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Intraoperative Neuromonitoring Market: Type Estimates & Trend Analysis

  • 4.1. Intraoperative Neuromonitoring Market: Key Takeaways
  • 4.2. Intraoperative Neuromonitoring Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Insourced
    • 4.3.1. Insourced market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Outsourced
    • 4.4.1. Outsourced market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Intraoperative Neuromonitoring Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Intraoperative Neuromonitoring Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Natus Medical Incorporated
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Accurate Monitoring
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Neuromonitoring Technologies
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Medtronic
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. NuVasive, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. SpecialtyCare
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 6 Europe intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 7 Europe intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 9 UK intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 10 France intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 11 Italy intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 12 Spain intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 13 Sweden intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 14 Norway intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 15 Denmark intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 18 Japan intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 19 China intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 20 India intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 21 Australia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 22 Thailand intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 23 South Korea intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 24 Latin America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 25 Latin America intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 28 Argentina intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 33 UAE intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Intraoperative neuromonitoring: Market outlook
  • Fig. 8 Intraoperative neuromonitoring: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Intraoperative neuromonitoring market driver impact
  • Fig. 14 Intraoperative neuromonitoring market restraint impact
  • Fig. 15 Intraoperative neuromonitoring market strategic initiatives analysis
  • Fig. 16 Intraoperative neuromonitoring market: Type movement analysis
  • Fig. 17 Intraoperative neuromonitoring market: Type outlook and key takeaways
  • Fig. 18 Insourced market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Outsourced market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Global intraoperative neuromonitoring market: Regional movement analysis
  • Fig. 21 Global intraoperative neuromonitoring market: Regional outlook and key takeaways
  • Fig. 22 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)